As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
The allergy treatment industry is driven by the increasing investment by the manufacturers towards the development of novel allergic treatments, owing to the increasing cases of eye allergy and asthma. Over the forecast period, the innovative launch of immunotherapy products and their approval by the governments is likely to be a major factor driving the market. In addition, the rising concerns pertaining to allergies among infants and geriatrics are expected to further aid the market.
The increasing investments by the leading industry players to develop improved treatment options are expected to further aid the market growth in the forecast period. For instance, in February 2020, Aimmune Therapeutics took a decision to spend USD 10 million to in-license an experimental anti-allergenic biological drug from Xencor (NASDAQ: XNCR). The license was granted to Aimmune Therapeutics, which will lead to the development and commercialisation of investigational humanised monoclonal antibody XmAb7195. In another case, in February 2020, Glenmark Pharmaceuticals Ltd and Hikma Pharmaceuticals Plc entered into an exclusive licensing agreement for commercialising its novel nasal spray Ryaltris for the treatment of allergic rhinitis.
In terms of region, North America is likely to account for a significant share in the market, owing to the growing awareness about the fatality of allergies. The easy availability of antihistamines, especially in developed countries like the United States, is likely to aid the allergy treatment industry growth.
Market Breakup by Type, Treatment, and Region:
Key Findings of the Report:
Key Offerings of the Report:
The major players in the global allergy treatment market are AbbVie Inc., GlaxoSmithKline PLC, F. Hoffmann-La Roche Ltd., Johnson & Johnson Services, Inc., Sanofi S.A., and LETI Pharma, S.L.U., among others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.
Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.
EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.
Expert Market Research
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.